CAC Software vs Viz AAA
AI Verdict
Choose CAC Software if…
Choose Imbio's CAC Software if your primary objective is to quantify coronary artery calcification from non-contrast chest CT scans for cardiovascular risk assessment. This tool is ideal for radiologists and cardiologists needing automated Agatston scores, arterial age, and 3D visualizations to support early detection and management of coronary artery disease.
View CAC Software →Choose Viz AAA if…
Choose Viz AAA if your priority is the rapid detection, triage, and coordinated care for suspected Abdominal Aortic Aneurysm (AAA) cases. This solution is best suited for emergency medicine, radiology, and vascular surgery teams requiring AI-powered alerts and a HIPAA-compliant communication platform to accelerate treatment decisions and improve patient outcomes for acute aortic pathologies.
View Viz AAA →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | CAC Software | Viz AAA |
|---|---|---|
| Pricing | Unknown | Enterprise (hospital/health system) |
| Deployment | Cloud-based (SaaS), integrates with PACS | Cloud-based, integrates with PACS and EHR systems. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Viz AAAViz AAA offers a more comprehensive suite of usability features, including real-time alerts, a HIPAA-compliant communication platform, and mobile access to imaging and patient information, which extends beyond image processing to active care coordination for the entire care team. While CAC Software integrates well into existing DICOM workflows and operates automatically, Viz AAA's features facilitate faster action and collaboration across multidisciplinary teams.
Clinical Value
Viz AAABoth tools offer significant clinical value in their distinct domains. However, Viz AAA's focus on the rapid detection and triage of suspected Abdominal Aortic Aneurysms (AAA), a time-critical and life-threatening condition, and its claim as the first FDA-cleared AI solution for this purpose, suggests a more immediate and impactful clinical benefit by accelerating treatment decisions and potentially preventing catastrophic events. CAC Software provides valuable quantitative risk assessment for coronary artery disease, but AAA detection and triage often require more urgent intervention.
Pricing & Value
TieNeither tool provides transparent public pricing, making a direct comparison of value difficult. Viz AAA specifies a subscription model based on the number of algorithms and population served, offering a slight indication of its pricing structure. However, without actual figures or clear pricing tiers for either product, it is impossible to definitively assess which offers better value.
Enterprise Readiness
CAC SoftwareBoth tools demonstrate strong enterprise readiness with FDA clearance, HIPAA compliance, and BAA availability. However, CAC Software offers greater deployment flexibility, supporting cloud, on-premise, and integration with various partner platforms, which can be crucial for diverse hospital IT environments. Viz AAA is primarily cloud-based.
Innovation
Viz AAAViz AAA stands out as the 'first FDA-cleared AI-powered solution' for the detection and triage of suspected AAA, indicating a pioneering role in its specific application. Its comprehensive approach, integrating AI detection with real-time alerts and a secure communication platform for care coordination, represents a significant innovation in accelerating critical treatment decisions for a time-sensitive condition. While CAC Software utilizes deep learning and provides advanced quantification, Viz AAA's integrated workflow and regulatory achievement give it an edge.
Support & Docs
Viz AAAViz.ai provides a comprehensive 'Trust Center' with readily accessible documentation, including SOC 2 Type II Report, HIPAA Compliance Documentation, and ISO Certificates, demonstrating a high level of transparency regarding its security and privacy posture. They also offer a 'Help Center' and 'User Guides'. While Imbio provides phone and email support and offers user manuals upon request, Viz.ai's publicly available and extensive compliance documentation offers a more robust and transparent support ecosystem for enterprise customers.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | CAC Software | Viz AAA |
|---|---|---|
| Name | CAC Software | Viz AAA |
| Company | Imbio | Viz.ai |
| Primary Use Case | Automated image post-processing to determine location and calculate amount of calcification within coronary arteries from non-contrast chest CT. | AI-powered detection and triage of suspected Abdominal Aortic Aneurysm (AAA) from CT angiography scans. |
| Key Outputs / Specific Functionality | Outputs Agatston score, arterial age, calcified lesion mass and volume; provides 3D visualizations and annotated images; integrates into existing DICOM viewing workflow. | AI-powered automatic detection of suspected AAA; automated triage and prioritization of cases; real-time alerts to care teams; HIPAA-compliant communication platform; mobile access to high-fidelity imaging and patient information. |
| Specialties | Cardiology, Radiology | Emergency Medicine, Radiology, Vascular Surgery |
Videos
Demos, reviews, and walkthroughs featuring CAC Software and Viz AAA.